UNSPSC 51203501: Ciamexon

This classification denotes a biological response modifier with the molecular formula C11H13N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 325PG708LF, chemically known as 2-aziridinecarbonitrile, 1-((2-methoxy-6-methyl-3-pyridinyl)methyl)- but more generally known as ciamexon, which bears US NIH Compound Identifier 71759. European Medicines Agency schedules Ciamexon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06224MIG.

UNSPSC 51203501 Ciamexon is a Commodity code that covers pharmaceutical products and opioid antagonists procured by state and local governments for community health, emergency response, and pharmacy benefit programs. Recent solicitations show state and local buyers acquiring naloxone and drug deactivation systems for public health initiatives, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and medical and first aid supplies including respiratory equipment and cardiac monitoring devices for fire rescue operations. The mix of issuing bodies includes county health departments, state health agencies, municipal fire departments, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The scope of work spans both emergency medical supplies and broader pharmacy benefit administration, reflecting both tactical procurement of specific pharmaceutical items and strategic state-level programs to manage prescription fulfillment and cost control.

Geographic activity centers on Florida and Minnesota, with Texas participating in exploratory procurement for direct-to-manufacturer prescription programs. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, structured for quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa's Purchasing Department solicited medical and first aid supplies (IFB 26P00145) with a response deadline of March 13, 2026 and an estimated contract value of $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement, acting through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, distributed through authorized wholesalers to state and local government facilities including Oregon. The Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs, signaling intent to develop future formal procurement specifications for pharmacy benefit management.